The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab

The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab The Pharmacogenomics Journal advance online publication, July 18 2017. doi:10.1038/tpj.2017.37 Authors: T Magnes, T Melchardt, C Hufnagl, L Weiss, C Mittermair, D Neureiter, E Klieser, G Rinnerthaler, S Roesch, A Gaggl, R Greil & A Egle
Source: The Pharmacogenomics Journal - Category: Drugs & Pharmacology Authors: Source Type: research